Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lin, Yuanyuan
NCT04373967: Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes	Recruiting	3	424	RoW	Victoza®., Metformin Hydrochloride, TQZ2451	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Type 2 Diabetes	12/21	12/21
Symphony2, NCT06353347: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin	Active, not recruiting	3	551	RoW	HTD1801, berberine ursodeoxycholate, Placebo	HighTide Biopharma Pty Ltd	Type 2 Diabetes Mellitus	03/25	12/25
Zhao, Xianming
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System	Not yet recruiting	N/A	2150	RoW	Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy	Lepu Medical Technology (Beijing) Co., Ltd.	Coronary Heart Disease	01/26	01/28
Li, Xianfeng
NCT05908695: An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease	Recruiting	4	1312	RoW	GV-971, Placebo	Green Valley (Shanghai) Pharmaceuticals Co., Ltd.	Alzheimer's Disease	06/29	12/29
Zhaojun, Xiong
No trials found